Human Papillomavirus (HPV) Vaccines — CPB 0726 | AETNA Coverage Update

TL;DR: Aetna, a CVS Health company, modified CPB 0726 for HPV vaccines, effective November 27, 2025. Here's what billing teams need to know before submitting claims.

The Aetna HPV vaccine coverage policy under CPB 0726 Aetna system draws a sharp line: CPT 90651 (Gardasil 9, the 9-valent vaccine) is covered for patients ages 9 to 45, and CPT 90649 and 90650 are explicitly not covered. If your practice bills HPV vaccines to Aetna-covered members, this policy update affects your charge capture, your ICD-10 pairings, and your exposure on claim denial. Read through the full breakdown before the November 27, 2025 effective date locks in.

---

Quick-Reference Table

Field	Detail Copy
Payer	Aetna, a CVS Health company
Policy	Human Papillomavirus (HPV) Vaccines
Policy Code	CPB 0726
Change Type	Modified
Effective Date	November 27, 2025
Impact Level	Medium
Specialties Affected	Pediatrics, Family Medicine, OB/GYN, Internal Medicine, Adolescent Medicine
Key Action	Remove CPT 90649 and 90650 from your Aetna charge capture and confirm all HPV vaccine claims use CPT 90651

---

Aetna HPV Vaccine Coverage Criteria and Medical Necessity Requirements 2025

Aetna's HPV vaccine coverage policy is built entirely around one product: Gardasil 9, billed under CPT 90651. The medical necessity criteria are clear — Aetna covers the 9-valent HPV vaccine for any person age 9 through 45.

Age eligibility is broader than many billing teams assume. Coverage extends well past the typical adolescent window. A 40-year-old presenting for first-dose HPV vaccination billing under CPT 90651 is covered under this policy, provided the plan includes preventive services.

That last qualifier matters. Not all Aetna plans cover preventive services. Before billing 90651 with administration codes 90471 or 90472, confirm the member's benefit plan includes preventive coverage. A reimbursement denial on a vaccine claim is almost always a benefits verification problem, not a coding problem.

The medical necessity question gets more specific for patients who completed earlier HPV vaccine series. Aetna considers Gardasil 9 not medically necessary for any patient who already finished a three-dose series with Gardasil (CPT 90649) or Cervarix (CPT 90650). One clean exception: if your practice doesn't have documentation of which vaccine product was previously used, or if you're mid-transition to Gardasil 9, continuing or completing the series with 90651 is still considered medically necessary.

This is the real operational issue for practices transitioning product inventory. Document vaccine history before administering. If records are unavailable, note that in the chart to support medical necessity if you face a prior authorization request or post-payment audit.

There's no prior authorization requirement called out in the policy for the covered indication. But if you're seeing prior auth requests come through anyway, that's a plan-level variation — check the specific member's benefit plan before assuming blanket approval.

---

Aetna HPV Vaccine Exclusions and Non-Covered Indications

Seven categories draw the "experimental, investigational, or unproven" designation under CPB 0726. These are the denials that blindside billing teams when a provider documents a clinical rationale outside preventive use.

The policy is explicit that this list is not all-inclusive. That's worth flagging to your medical director. Aetna won't cover HPV vaccination billed as treatment or adjunctive therapy for any of the following:

The real issue here is ICD-10 pairing. If a provider documents any of these diagnoses in the encounter and your biller links them to CPT 90651 on the claim, you're looking at a claim denial regardless of clinical intent. The billing guidelines demand a clean preventive indication for payment.

If your practice treats patients with cervical dysplasia or anogenital warts and a provider wants to vaccinate as part of that encounter, that claim won't survive on a therapeutic diagnosis code. If there's a legitimate separate preventive visit component, bill it separately with the correct preventive ICD-10. If you're not sure how to structure that, loop in your compliance officer before submitting.

---

Coverage Indications at a Glance

---

Aetna HPV Vaccine Billing Guidelines and Action Items 2025

Copy Action Items

---

CPT, HCPCS, and ICD-10 Codes for HPV Vaccines Under CPB 0726

Covered CPT Codes (When Selection Criteria Are Met)

Code	Type	Description Copy
90651	CPT	Human Papillomavirus vaccine types 6, 11, 16, 18, 31, 33, 45, 52, 58, nonavalent (9vHPV), 3 dose schedule

Administration CPT Codes (Related to CPB 0726)

Code	Type	Description Copy
90471	CPT	Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injection)
90472	CPT	Each additional vaccine (single or combination vaccine/toxoid) — list separately in addition to primary administration code

Not Covered CPT Codes

Code	Type	Description	Reason Copy
90649	CPT	Human Papillomavirus vaccine, types 6, 11, 16, 18, quadrivalent (4vHPV), 3 dose schedule, for intramuscular use	Not covered — product no longer distributed in the U.S.
90650	CPT	Human papillomavirus vaccine, types 16, 18, bivalent (2vHPV), 3 dose schedule, for intramuscular use	Not covered — product no longer distributed in the U.S.

HCPCS Codes Related to CPB 0726

Code	Type	Description Copy
D1781	HCPCS	Vaccine administration – human papillomavirus – Dose 1
D1782	HCPCS	Vaccine administration – human papillomavirus – Dose 2
D1783	HCPCS	Vaccine administration – human papillomavirus – Dose 3

Key ICD-10-CM Diagnosis Codes

---